维普期刊资源整合服务平台（V6.5）

74篇 您的检索式：作者名="Bullinger L"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Aberrant expression of miR-9/9^* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG显示文摘	Nowek K Sun S M Bullinger L	2016	Leukemia2016，30，1：	1
2	AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias 显示文摘	Sykes SM Lane SW Bullinger L	2011	Cell2011，146，5：	1
3	AKT/FOXO signaling en-forces reversible differentiation blockade in myeloid leukemias显示文摘	Sykes S M Lane S W Bullinger L	2011	Cell2011，146，5：	1
4	An FL T3 gene-expression signature predicts clinical out?come in normal karyotype AML显示文摘	BULLINGER L DOHNER K KRANZ R	2008	Blood2008，111，：	1
5	AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias显示文摘	Sykes SM Lane SW Bullinger L		0，，：	1
6	Genetic and pharmacologic inhibition of beta-catenin targets imatinib-resistant leukemia stem cells in CML显示文摘	Heidel FH Bullinger L Feng Z	2012	Cell Stem Cell2012，10，4：	1
7	Genetics of chronic lymphocytic leukemia:genomic aberrations and V (H) gene mutation status in pathogenesis and clinical course显示文摘	Stilgenbauer S Bullinger L Lichter P	2002	Leukemia2002，16，6：	1
8	DNMT3A mutations in myeloproliferative neoplasms显示文摘	Stegelmann F Bullinger L Schlenk RF	2011	Leukemia2011，25，7：	1
9	RUNX1 mutations in acute myeloid leukemia: re- sults from a comprehensive genetic and clinical analy- sis from the AML study group显示文摘	GAIDZIK V I BULLINGER L SCHLENK R F	2011	J Clin Oncol2011，29，：	1
10	Alterations of the cyclinD1/P16-pRb pathway in mantale cell lymphomal显示文摘	Dreyling MH Bullinger L Ott G	1997	Cancer Res1997，57，20：	1
11	Genomic aberrations in mantle cell lymphoma detected by intcrphase fluorescence in situ hybridization:incidence and clinicopathological correlations显示文摘	Sander S Bullinger L Leupoh E	2008	Hematologica2008，93，5：	1
12	Prognostic impact,concurrent genetic mutations,and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients:further evidence for CEBPA double mutant AML as a distinctive disease entity显示文摘	Taskesen E Bullinger L Corbacioglu A	2011	Blood2011，117，：	1
13	Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization 显示文摘	Rucker FG Bullinger L Schwaenen C	2006	J Clin Oncol2006，24，24：	1
14	Genetic and pharmacologic inhibition of beta-catenin targets imatinibresistant leukemia stem cells in CML显示文摘	Heidel FH Bullinger L Feng Z	2012	Cell Stem Cell2012，10，4：	1
15	AKT/FOXO Signaling enforces reversible differentiation blockade in myeloid leukemias显示文摘	Sykes S M Lane S W Bullinger L Kalaitzidis D Yusuf R Saez B Ferraro F Mercier F Singh H Brumme K M Acharya S S Scholl C Tothova Z Attar E C Fr?hling S DePinho R A Armstrong S A Gilliland D G Scadden D T		0，，05：	1
16	MYC stimulates EZH2expression by repression of its negative regulator miR-26a显示文摘	Sander S Bullinger L Klapproth K	2008	Blood2008，112，10：	1
17	Alterations of the cyclin D1/P16-pRb pathway in mantle cell lymphomal显示文摘	Dreyling MH Bullinger L Ott G	1997	Cancer Res1997，57，20：	1
18	Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia 显示文摘	Mar B G Bullinger L Basu E	2012	Leukemia2012，26，8：	1
19	Alterations of the cyclinD1/P16-pRb pathway in mantle cell lymphoma 显示文摘	Dreyling MH Bullinger L Ott G	1997	Cancer Res1997，57，20：	1
20	Alterations of the cyclinD1/P16-pRb pathway in mantle cell lymphoma显示文摘	DREYLING M H BULLINGER L OTT G	1997	Cancer Res1997，57，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示